Concepedia

Todd Borland

TB

5

Publications

4.1K

Citations

5

H-Index

2008

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Todd Borland is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, immunology, and gene delivery.

Top concepts

MedicineImmunologyEngineeringNanomedicineGene DeliveryBiomolecular EngineeringVirologyPathologyTherapeuticsGenome Editing

Publications per year

2008–2016

5

Publications

5

Rational design of cationic lipids for siRNA delivery

Sean C. Semple, Akin Akinc, Jianxin Chen et al. · Nature Biotechnology · 2010 · 1.7K citations

Lipid Preparation, Nanomedicine, Engineering +3

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg et al. · Nature Biotechnology · 2008 · 1.2K citations

Cell-based Drug Delivery, Nanomedicine, Lipid Preparation +9

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Teresa Coelho, David Adams, Ana Silva et al. · New England Journal of Medicine · 2013 · 947 citations · Full text

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

Rene Alvarez, Sayda M. Elbashir, Todd Borland et al. · Antimicrobial Agents and Chemotherapy · 2009 · 144 citations · Full text

Viral Replication, Respiratory Virus Immunity, Potent Antiviral Strategy +16

Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis

James S. Butler, Amy Chan, Susete Costelha et al. · Amyloid · 2016 · 114 citations · Full text

Translational Medicine, Attr Amyloidosis, Ttr Amyloid +13

Rows per page

1–5 of 5